CSPC pharmaceutical reports stable issued share capital for August

CSPC Pharmaceutical Group Limited (HKEX:1093) has submitted its monthly return for the period ended August 31, 2025, indicating a stable issued share capital. As of the end of August, the total number of issued ordinary shares remained at 11,521,951,732, with no increase or decrease during the month. Similarly, the number of treasury shares held by the company remained at zero.

The report also detailed the status of the 2015 Share Option Scheme, adopted on December 9, 2015. Under this scheme, 1,800,000 share options were outstanding at the close of August 2025, unchanged from the preceding month. The total number of shares that may be issued or transferred out of treasury upon the exercise of all share options to be granted under the scheme remains substantial, at 566,101,840.

During August 2025, there were no new shares issued from the exercise of share options, nor were any treasury shares transferred out pursuant to the scheme. Consequently, the total funds raised from the exercise of options during the month were HKD0. The company confirmed no other movements in its issued shares or treasury shares for the reported period.